🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of L-Carnitine Supplementation in Preterm Neonates

RecruitingNAAges 1 Hour - 24 HoursAllMuhammad Aamir Latif
NCT07437391 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Preterm neonates * Either gender * With RDS * Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth . Exclusion Criteria: * Neonates with gastrointestinal tract (GIT) anomalies * With confirmed or suspected sepsis at the time of enrollment * Neonates whose clinical condition contraindicates study participation (e.g., expected survival \<48 hours, as judged by the neonatologist).
💊

What it tests

  • L-carnitine
  • Standard care
📍

Where

1 site
Recep Tayyip Erdogan Hospital/Indus Hospital & Health Network
Muzaffargarh, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy